181 related articles for article (PubMed ID: 6450639)
1. Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.
Bhuyan BK; McGovren JP; Crampton SL
Cancer Res; 1981 Mar; 41(3):882-7. PubMed ID: 6450639
[No Abstract] [Full Text] [Related]
2. Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
Bhuyan BK; Blowers CL; Crampton SL; Shugars KD
Cancer Res; 1981 Jan; 41(1):18-24. PubMed ID: 7448758
[TBL] [Abstract][Full Text] [Related]
3. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
[No Abstract] [Full Text] [Related]
4. Lethality of nogalamycin, nogalamycin analogs, and adriamycin to cells in different cell cycle phases.
Bhuyan BK; Blowers CL; Shugars KD
Cancer Res; 1980 Oct; 40(10):3437-42. PubMed ID: 7438031
[TBL] [Abstract][Full Text] [Related]
5. Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
Adams EG; Bhuyan BK
Cancer Res; 1986 Dec; 46(12 Pt 1):6125-30. PubMed ID: 2946401
[TBL] [Abstract][Full Text] [Related]
6. Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
Adams EG; Crampton SL; Bhuyan BK
Cancer Res; 1981 Dec; 41(12 Pt 1):4981-7. PubMed ID: 6458356
[TBL] [Abstract][Full Text] [Related]
7. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
8. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
Chandrasekaran B; Dimling J; Capizzi RL
Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline analogs: the past, present, and future.
Weiss RB; Sarosy G; Clagett-Carr K; Russo M; Leyland-Jones B
Cancer Chemother Pharmacol; 1986; 18(3):185-97. PubMed ID: 2948729
[No Abstract] [Full Text] [Related]
10. Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agent.
Egorin MJ; Clawson RE; Cohen JL; Ross LA; Bachur NR
J Pharmacol Exp Ther; 1979 Aug; 210(2):229-36. PubMed ID: 458629
[TBL] [Abstract][Full Text] [Related]
11. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
McGovren JP
Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
[TBL] [Abstract][Full Text] [Related]
12. The disposition of the new anthracycline antibiotic, menogarol, in mice.
Dodion P; Chang BK; Egorin MJ; Olman EA; Engisch KL; Bachur NR
Drug Metab Dispos; 1984; 12(3):365-70. PubMed ID: 6145565
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.
Zanette ML; Tirelli U; Sorio R; Zadro D; Figoli F; Monfardini S; D'Incalci M
Cancer Chemother Pharmacol; 1987; 20(1):67-70. PubMed ID: 2957106
[TBL] [Abstract][Full Text] [Related]
14. Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.
Wierzba K; Sugimoto Y; Matsuo K; Toko T; Takeda S; Yamada Y; Tsukagoshi S
Jpn J Cancer Res; 1990 Aug; 81(8):842-9. PubMed ID: 2144516
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of menogaril in patients with advanced cancer.
Brown TD; Donehower RC; Grochow LB; Rice AP; Ettinger DS
J Clin Oncol; 1987 Jan; 5(1):92-9. PubMed ID: 2949065
[TBL] [Abstract][Full Text] [Related]
16. Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents.
Bhuyan BK; Zimmer DM; Mazurek JH; Trzos RJ; Harbach PR; Shu VS; Johnson MA
Cancer Res; 1983 Nov; 43(11):5293-7. PubMed ID: 6225515
[TBL] [Abstract][Full Text] [Related]
17. Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma.
Brown JE; Wilkinson PA; Brown JR
J Chromatogr; 1981 Dec; 226(2):521-5. PubMed ID: 6459335
[No Abstract] [Full Text] [Related]
18. In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
Dodion P; Sanders C; Rombaut W; Rozencweig M; Kitt MM; Kenis Y; Klastersky J
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):245-9. PubMed ID: 2940092
[TBL] [Abstract][Full Text] [Related]
19. Synergistic combination of menogarol and melphalan and other two drug combinations.
Bhuyan BK; Adams EG; Johnson M; Crampton SL
Invest New Drugs; 1985; 3(3):233-44. PubMed ID: 2933360
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable chimaeric polymersomes mediate highly efficient delivery of exogenous proteins into cells.
Cheng R; Liu G; Ma S; Li S; Meng F; Liu H; Zhong Z
J Control Release; 2011 Nov; 152 Suppl 1():e136-7. PubMed ID: 22195804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
